PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX Appoints Former Array BioPharma Executive to Key Role, page-2

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Standout appointment..., well done team PTX.
    Expertise is licensing closer back with academic peer reviewing and strategic patent identification.
    Another excellent forward thinking move.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.